LYB remained sharply focused on executing its three-pillar strategyGenerated $3.8 billion of cash from operating activities with 90% cash ...

Dupixent continues leading among Sanofi’s portfolio, and it’s poised for up to $20 billion in peak sales. Read my SNY ...

The Railway Recruitment Board (RRB) has released the Group D notification for the recruitment of eligible candidates for ...